Multiomic Mass Spectrometry Imaging to Advance Future Pathological Understanding of Ocular Disease.

MILLAR, Joshua, OZAKI, Ema, CAMPBELL, Susan, DUCKETT, Catherine, DOYLE, Sarah and COLE, Laura (2022). Multiomic Mass Spectrometry Imaging to Advance Future Pathological Understanding of Ocular Disease. Metabolites, 12 (12): 1239.

[img]
Preview
PDF
Cole-MultiomicMassSpectrometry(VoR).pdf - Published Version
Creative Commons Attribution.

Download (10MB) | Preview
Official URL: https://www.mdpi.com/2218-1989/12/12/1239
Link to published version:: https://doi.org/10.3390/metabo12121239
Related URLs:

Abstract

Determining the locations of proteins within the eye thought to be involved in ocular pathogenesis is important to determine how best to target them for therapeutic benefits. However, immunohistochemistry is limited by the availability and specificity of antibodies. Additionally, the perceived role of both essential and non-essential metals within ocular tissue has been at the forefront of age-related macular degeneration (AMD) pathology for decades, yet even key metals such as copper and zinc have yet to have their roles deconvoluted. Here, mass spectrometry imaging (MSI) is employed to identify and spatially characterize both proteomic and metallomic species within ocular tissue to advance the application of a multiomic imaging methodology for the investigation of ocular diseases.

Item Type: Article
Uncontrolled Keywords: LA-ICP-MSI; MALDI-MSI; SARM1; age-related macular degeneration; copper; multimodal; ocular disease; zinc; 0301 Analytical Chemistry; 0601 Biochemistry and Cell Biology; 1103 Clinical Sciences
Identification Number: https://doi.org/10.3390/metabo12121239
SWORD Depositor: Symplectic Elements
Depositing User: Symplectic Elements
Date Deposited: 03 Jan 2023 17:52
Last Modified: 12 Oct 2023 08:17
URI: https://shura.shu.ac.uk/id/eprint/31235

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year

View more statistics